In genome-wide association studies, performed mostly in nondiabetic individuals, genetic variability of glucokinase regulatory protein (GCKR) affects type 2 diabetes-relatedphenotypes, kidney function, and risk of chronic kidney disease (CKD). We tested whether GCKR variability affects type 2 diabetes or kidney-related phenotypes in newly diagnosed type 2diabetes. In 509 GAD-negative patients with newly diagnosedtype 2 diabetes,we 1) genotyped six single nucleotide polymorphisms in GCKR genomic region: rs6717980, rs1049817, rs6547626, rs780094, rs2384628, and rs8731; 2) assessedclinical phenotypes, insulin sensitivity by the euglycemic insulin clamp, and b-cell function by state-of-the-art modeling of glucose/C-peptide curves during an oral glucose tolerance test;and 3) estimated glomerular filtration rate (eGFR) by the Modification of Diet in Renal Disease formula.The major alleles of rs6717980 and rs2384628 were associated with reduced b-cell function (P<0.05), with mutual additive effects of each variant (P<0.01). The minoralleles of rs1049817 and rs6547626 and the major allele of rs780094 were associated withreduced eGFR according to a recessive model (P<0.03), but with no mutual additive effects of the variants. Additional associations were found between rs780094 and 2-h plasma glucose(P<0.05) and rs8731 and insulin sensitivity (P<0.05) and triglycerides (P<0.05). Our findings are compatible with the idea that GCKR variability may play a pathogenetic role in both type 2 diabetes and CKD. Genotyping GCKR in patients withnewly diagnosed type 2 diabetes might help in identifying patients at high risk for metabolic derangements or CKD.

Variants of GCKR affect both beta cell and kidney function in patients with newly diagnosed type 2 diabetes. The Verona Newly diagnosed type diabets study (VNDS). 2.

BONETTI, Sara;TROMBETTA, Maddalena;BOSELLI, Maria Linda;TURRINI, Fabiola;MALERBA, Giovanni;TRABETTI, Elisabetta;PIGNATTI, Pierfranco;BONORA, Enzo;
2011-01-01

Abstract

In genome-wide association studies, performed mostly in nondiabetic individuals, genetic variability of glucokinase regulatory protein (GCKR) affects type 2 diabetes-relatedphenotypes, kidney function, and risk of chronic kidney disease (CKD). We tested whether GCKR variability affects type 2 diabetes or kidney-related phenotypes in newly diagnosed type 2diabetes. In 509 GAD-negative patients with newly diagnosedtype 2 diabetes,we 1) genotyped six single nucleotide polymorphisms in GCKR genomic region: rs6717980, rs1049817, rs6547626, rs780094, rs2384628, and rs8731; 2) assessedclinical phenotypes, insulin sensitivity by the euglycemic insulin clamp, and b-cell function by state-of-the-art modeling of glucose/C-peptide curves during an oral glucose tolerance test;and 3) estimated glomerular filtration rate (eGFR) by the Modification of Diet in Renal Disease formula.The major alleles of rs6717980 and rs2384628 were associated with reduced b-cell function (P<0.05), with mutual additive effects of each variant (P<0.01). The minoralleles of rs1049817 and rs6547626 and the major allele of rs780094 were associated withreduced eGFR according to a recessive model (P<0.03), but with no mutual additive effects of the variants. Additional associations were found between rs780094 and 2-h plasma glucose(P<0.05) and rs8731 and insulin sensitivity (P<0.05) and triglycerides (P<0.05). Our findings are compatible with the idea that GCKR variability may play a pathogenetic role in both type 2 diabetes and CKD. Genotyping GCKR in patients withnewly diagnosed type 2 diabetes might help in identifying patients at high risk for metabolic derangements or CKD.
2011
GCKR variants; β-cell and kidney function
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11562/348805
Citazioni
  • ???jsp.display-item.citation.pmc??? 13
  • Scopus 28
  • ???jsp.display-item.citation.isi??? 26
social impact